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 A beneficial effect of applying mild stress to cells or organisms, that were initially
exposed to a high dose of stress, has been referred to as ‘postconditioning hormesis’. The
initial high dose of stress activates intrinsic self-recovery mechanisms. Modulation of these
endogenous adaptation strategies by administration of a subsequent low dose of stress can
confer effects that are beneficial to the biological system. Owing to its potentially thera-
peutic applications, postconditioning hormesis is subject to research in various scientific
disciplines. This paper presents an overview of the dynamics of postconditioning horme-
sis and illustrates this phenomenon with a number of examples in experimental and clin-
ical research.
Keywords: hormesis, postconditioning, postexposure, adaptive response, preconditioning.
INTRODUCTION
Adaptation of cells and organisms (in response) to particular types of
environmental stress is a widely studied phenomenon. Different types of
stress include, for example, allergens, pathogens, ischemia, exercise,
heavy metals or psychologically induced stress. Remarkably, instead of
causing a continuously linear increase or decrease in response with dose,
most of these stresses seem to act in accordance with a non-linear dose-
response relationship known as the biphasic response. It is characterized
by a J-shaped or an inverted U-shaped dose response curve representing
low dose stimulation and high dose inhibition and is indicated with the
term hormesis (Calabrese and Baldwin 2002a; Calabrese et al. 2007).
The phenomenon of hormesis has frequently been reported using a
different nomenclature: for example, dose-response relationships are
explained according to the Yerkes-Dodson Law in experimental psychol-
ogy; the term subsidy-gradient is used in the area of ecological analysis;
functional antagonism is employed nearly exclusively in enzymology; the
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U-shaped response, albeit applied in a wider range of disciplines, is com-
monly used in epidemiology; adaptive response is a term classically
employed in molecular biology and physiology; biphasic response is fre-
quently used in pharmacology; hormesis, finally, is the term that is most
established in the area of toxicology where it was first mentioned
(Calabrese 2008a). What these phenomena have in common is that their
response relates biphasically to particular doses of stress. Such dose-
response relationships are qualitatively independent of the stress-induc-
ing agent, the endpoint measured and the system under investigation
(Agutter 2008). Since no detailed explanatory mechanism for this evolu-
tionary conserved phenomenon currently exists, unification of the
hormesis-nomenclature is thwarted. Owing to Calabrese and others the
term hormesis has gained wider general acceptance and, importantly, has
increasingly come into use in the different scientific disciplines men-
tioned above (Calabrese and Baldwin 1998, 2002b, 2003; Calabrese et al.
2007). With numerous publications in various scientific journals,
Calabrese has significantly contributed to the general acceptance of this
evolutionarily conserved mechanism in the scientific world. Recently,
researchers from various scientific fields have agreed on the universality
of the phenomena they are studying (i.e., adaptive response, resilience,
preconditioning stimulation) and, as proposed by Calabrese and col-
leagues, have agreed to use the term hormesis (Calabrese et al. 2007).
“Evolutionarily conserved” refers to the fact that throughout evolu-
tion, a specific phenomenon and its underlying mechanism has general-
ly enhanced survival of the host and has therefore been preserved.
“Adaptive” relates to intrinsic self-recovery mechanisms up-regulated in
response to exposure to stress and possibly over-activation of these
processes as a means of coping with the unpredictability of exposure to
subsequent (other) stresses. The biphasic dose-response pattern is now
generally thought to reflect the activation of the adaptive capacity of bio-
logical systems in response to stress (Agutter 2008; Mattson 2008).
Within the framework of hormesis, different approaches are used to
elicit an adaptive response. Commonly, a stimulating low dose of stress is
administered which initiates compensatory biological processes. These
mechanisms that have been conserved through evolution confer a pro-
tective effect against exposure to a subsequent severe stress. This phe-
nomenon is known as preconditioning hormesis. Less conventional is the
administration of a low dose of stress to enhance repair and recovery
processes after exposure to a more severe stress (Calabrese et al. 2007;
Calabrese 2008b). The latter phenomenon is termed postconditioning
hormesis. ‘Post’ in this case refers to treatment with a low dose of stimu-
lating stress after an initial treatment with a large dose of stress.
‘Hormesis’ is the operational term used, and ‘conditioning’ pertains to
the conditioning element of hormesis (Calabrese et al. 2007). The term
F.A.C. Wiegant and others
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postconditioning hormesis may be preceded by the type of inducing
agent. For example, ischemic postconditioning hormesis which involves
low doses of hypoxic stress following a myocardial infarction, or chemical
postconditioning hormesis which involves exposure to low levels of a
chemical toxicant following a previous exposure to a severe stress condi-
tion such as a heat shock or a large amount of toxic agent, etc.
Depending on whether the low-dose stress administered during postex-
posure is of the same type of stress or is different from the initial high-
dose stress, postconditioning can be classified as homologous (i.e., the sub-
sequent stress is the same as the initial stress) or heterologous (i.e., the sub-
sequent stress is not the same as the initial stress).
Postconditioning, as part of the phenomenon of hormesis, is the
main focus of this review paper. The phenomenon of postconditioning
hormesis is not yet widely accepted. In this respect, Agutter (2008)
recently questioned the generality of this phenomenon: whether it was
indeed observed in numerous different biological systems or whether its
occurrence is more restricted. Moreover, it was questioned whether this
phenomenon has been observed at the cellular level or only in the con-
text of multicellular organisms such as humans.
In this overview, examples in various scientific fields will be described
where it has been recognized that, in addition to the protective effect of
mild stress against damage from a subsequent more severe stress (i.e., pre-
conditioning hormesis), application of a mild stress following a more
severe stress condition can also confer the beneficial effects of postcon-
ditioning hormesis (Jonas and Ives 2008; Ovelgönne et al. 1995; Van Wijk
et al. 1994a; Wiegant et al. 1997; Zhao 2007). In first instance, an example
is described of a molecular biology research program in which the bene-
ficial effect of mild doses of stress (including toxic compounds) has been
observed when applied to stressed cells within the post-conditioning
framework (eg Van Wijk et al. 1994a; Wiegant et al. 1997, 1998, 1999). In
addition, a possible explanatory model for postconditioning hormesis
will be discussed. Finally, some examples of clinical studies are described
in which application of mild stress following more severe stress or appli-
cation of mild stress to specific pathologic conditions appear to result in
promising beneficial effects.
POSTCONDITIONING HORMESIS; A MOLECULAR APPROACH
In their research program on the possible beneficial effect of post-
conditioning using mild stress conditions, Van Wijk and Wiegant (2006,
2010) utilized ‘in vitro’ cultured Reuber H35 rat hepatoma cells that
were pre-treated with an initial large dose of arsenite, cadmium or heat
shock stress, immediately followed by incubation with lower doses of the
initial stressor. Their program was focused in particular on the pro-
Postconditioning hormesis: an overview
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teotoxic response of cells and the regulation of stress protein synthesis.
Hightower (1991) was the first to coin the term ‘proteotoxicity’ to indi-
cate the detrimental action of damaged and denatured proteins that had
lost their normal shape and function. The detrimental action of these
denatured proteins in cells and organism has increasingly been recog-
nized as an important focus of interest in biomedical disciplines
(Gregersen et al. 2006; Morimoto 2008). A variety of adverse conditions,
such as: an enhanced temperature (heat shock), free radical stress, radi-
ation and heavy metals, can induce damage to cellular proteins. In
response to proteotoxicity, cells react with an upregulation of heat shock
proteins (hsps). These proteins function as molecular chaperones that
facilitate the folding of newly synthesized proteins and repair structural-
ly damaged proteins. In this way, the hsps are involved in repair, recov-
ery and defence of protein structure and function. There are different
families of these chaperone proteins (known as hsp28, hsp60, hsp70,
hsp90 and hsp100) (Ellis 2007). The presence of these stress proteins
lead to an increase in cell survival capacity under threatening condi-
tions. It has since been demonstrated that chaperones possess many
active functions: they repair structural damages by forcefully disentangle
aggregated proteins, unfold and refold them into ‘re-educated and born
again’ functional proteins (Csermely and Vigh 2007; Ellis 2007). It is of
interest that different stress conditions are able to induce characteristic
differences in the type and in the quantity of the various stress proteins
(Wiegant et al. 1994; Ryan and Hightower 1996). The question on which
the research program focused was whether a postconditioning effect can
be demonstrated at the molecular level of stress protein synthesis and on
changes in survival capacity. Both homologous and heterologous post-
conditioning effects were evaluated.
Homologous postconditioning hormesis
In first instance, post-exposure studies were carried out using the
homologous strategy. Cell cultures that were first exposed to a harmful
(high dose) stress condition were subsequently incubated with lower
doses of the initial stressor. When cells were damaged with chemical com-
pounds such as arsenite (100 or 300 µM) or cadmium (10 or 30 µM) and
subsequently exposed to low dose conditions of arsenite (1-10µM) or cad-
mium (0.1-1.0 µM) respectively, both hsp synthesis as well as survival
capacity were enhanced due to post-conditioning (Ovelgönne et al. 1995;
Wiegant et al. 1997). A further increase in hsp synthesis is interpreted as
a beneficial phenomenon, since more chaperones will be available to
assist in post-stress recovery (Van Wijk and Wiegant 2006; Wiegant and
Van Wijk 2010).
However, a relation was observed between the severity of the pre-
exposure- and the post-exposure condition. The more severe the initial
F.A.C. Wiegant and others
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stress condition, the smaller the concentration required for stimulating
hsp induction and survival capacity. When the initial stress condition has
been severe, small doses used in postconditioning can unexpectedly
merge into the harmful range. In this respect, it is of importance to note
that without high dose pretreatment, the low dose stress condition used
in post-exposure studies did not induce a detectable synthesis of stress
proteins (hsps) nor were they able to affect survival capacity.
To study the effect of homologous heat postconditioning, cells were
first exposed to a heat shock at 42°C or 43.5°C and subsequently incu-
bated at mild ‘fever-like’ temperatures. An enhanced survival capacity
and an enhanced synthesis of stress proteins were observed when the
initial heat shock was followed by a post-exposure to a lower hyperther-
mic (fever-like) temperature (Schamhart et al. 1992; Van Wijk et al.
1994a). Similar observations were reported by Delpino et al. (1992).
Also in these heat postconditioning studies the effect of low dose post-
exposure appeared to be related to the severity of the pre-exposure tem-
perature. Whereas the fever-like temperature enhanced survival capaci-
ty and hsp synthesis when applied ‘postconditionally’ following 42°C,
the same fever-like temperature depressed survival capacity and inhibit-
ed hsp synthesis when applied following exposure of cells to 43.5°C
(Van Wijk et al. 1994a).
These observations suggest a window of limited breadth for low doses
of stressors in which beneficial effects may occur upon postconditioning.
Heterologous postconditioning hormesis
An intriguing question relates to the specificity of the stimulation of
survival capacity and of hsp synthesis by postconditioning. In other words:
does an initial damaging condition only sensitizes a cell population to
stimulation by small doses of the same stress condition, or are cells also
stimulated by small doses of heterologous stressors? In this respect, it is of
interest that hormetic conditioning has been discussed with reference to
the homeopathic similia principle (Bellavite et al. 2006a, 2006b; Van Wijk
et al. 1994b; Van Wijk and Wiegant 2010). Samuel Hahnemann (1755-
1843), a German physician and chemist who founded the therapeutic
doctrine of homeopathy did so on the basis of the similia principle.
According to this therapeutic principle, the same substance that causes
the disease can be used in low doses to treat the disease (Bellavite et al.
2006b). In first instance, Hahnemann used dilutions of compounds,
whereas at a later stage, a specific preparatory process was introduced in
which ‘potencies’ are prepared using successive steps of dilution and suc-
cussion. These potencies may be diluted to such an extent that no mole-
cule of the original solution is present in the actual remedy. These ultra-
molecular potencies cause controversy since an explanation of their sug-
Postconditioning hormesis: an overview
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gested effect is still lacking. In the here described research program, no
ultramolecular but normal dilutions were used. According to the similia
principle, there exists a similitude between the symptoms induced by the
medicine and the symptoms of natural disease (Bellavite et al. 2006b).
From this point of view, to cure the disease, compounds or conditions
associated with the occurrence of particular symptoms can be used as
stimulators of intrinsic self-recovery which then facilitates the diseased
biological system to return to homeostasis (Van Wijk and Wiegant 2006;
Wiegant and Van Wijk 2010). At the cellular level, the pattern of induced
stress proteins (both heat shock proteins [hsps] and glucose-regulated
proteins [grps]) is stressor-specific and was considered in the research
program of Van Wijk and Wiegant as cellular ‘symptoms’ and hence as
the sole indication to direct research as to the choice of the low dose
agent to analyze its ability to exert beneficial effects in the recovery
process. In this way, the specificity of the similia principle was studied
(Wiegant et al. 1996, 1998, 1999). Following an initial heat shock, post-
conditioning included low doses of arsenite, several heavy metal ions
(cadmium, mercury, lead and copper), two different oxidative stress con-
ditions (menadion and diethyldithiocarbamate) and a mild (homolo-
gous) hyperthermic temperature. Different stressors were shown to
induce stressor-characteristic patterns of hsps (Wiegant et al.1994). Due
to a selective induction of specific stress proteins qualitative as well as
quantitative differences in hsp induction were observed. An example of a
qualitative difference was that lead (Pb) induces the glucose regulated
proteins (grp74 and grp94), which are not induced by other heavy met-
als, heat stress or oxidative stress and only slightly by arsenite. Another
example of a qualitative difference is that cadmium and ddtc do not
induce hsp60 whereas heat shock does. An example of a quantitative dif-
ference is that a specific hsp (such as hsp28) is induced to a different
degree by various stress conditions. The degree of similarity between the
pattern of hsps induced by the pre-exposure condition and those of the
low dose postconditioning treatment was established in first instance
(Wiegant et al. 1999). Then, in a set of experiments, cell cultures that
were pre-exposed to a heat shock were subsequently post-exposed to dif-
ferent low dose stress conditions.
It is of interest that postexposure of heat-shocked cells to different
chemical stress conditions demonstrated a differential stimulation of
both tolerance development and of heat shock protein synthesis
(Wiegant et al. 1999). The degree of stimulation appeared to depend on
the similarity of both the molecular and cellular effects of the stress con-
ditions used as initial disturbance and the postexposure treatment
(Wiegant et al. 1998, 1999). A more detailed elaboration of this research
program with respect to the evaluation of the similia principle at the cel-
lular level, has recently been described by Wiegant and Van Wijk (2010).
F.A.C. Wiegant and others
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Hahnemann’s similia similibus curentur (‘let like be cured by like’) was
met with much criticism and ridicule when it was introduced in the early
19th century. Up until today, neither the similia principle nor homeopa-
thy as a medical system have become incorporated in current Western
mainstream medicine. The comparative research on the relation between
postconditioning hormesis and the homeopathic similia principle seems
to offer an interesting challenge for both basic science and homeopathy
in the years to come.
Although postconditioning, as a part of hormesis, reflects the similia
principle, this is not necessarily so for the entire field of hormesis.
Hormesis may also include preconditioning hormesis wherein adminis-
tration of mild stress to a healthy system stimulates various adaptive mech-
anisms resulting in a protective effect against exposure to a subsequent,
larger stress. Therefore, the preconditioning part of hormesis might pri-
marily pertain to a medical prophylactic strategy, whereas postexposure
conditioning would then relate primarily to a therapeutic strategy.
POSTCONDITIONING HORMESIS: SALUTOGENESIS AND CLINICAL
UTILITY
Exactly which mechanisms underlie the phenomenon of postcondi-
tioning hormesis remains elusive. Yet the adaptive response mechanisms
it elicits provide a functional link to homeostasis, which is a universal bio-
logical concept (Calabrese and Baldwin 2002a). Postexposure condition-
ing, specifically, involves initial exposure to a large amount of stress, fol-
lowed by exposure to a much lower dose of stress. The initial severe stress
activates intrinsic self-recovery mechanisms of the biological system
which, subsequently, can be positively modulated by administration of a
low dose of stress. Due to the severity of the initial stress, compensation
that would otherwise return the system to the initial, balanced state
(homeostasis) may not be sufficient. The extent to which the system has
been brought out of balance determines the rates that control the main-
tenance of the state of the system.
Therefore, both homeostasis and homeorhesis should be consid-
ered in the control of states (Stebbing 2003). Together these principles
allow a biological system, in response to administration of a large
amount of stress, to adjust its rate and oscillate towards a state that is
optimal under its current circumstances (i.e. not necessarily the previ-
ous homeostatic state). Such a response is in line with the Law of Initial
Value (LIV), as proposed by Joseph Wilder (1895-1976) in 1935.
According to this law, “the direction of response of a body function to
any agent depends to a large degree on the initial level of that function”
(Wilder 1962). In postconditioning, exposure to the first severe stress
affects the initial level of the system. This initial level is now different
from that of a healthy biological system; rather, it has become unbal-
Postconditioning hormesis: an overview
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anced (i.e., diseased). With a corresponding alteration in homeorhesis,
exposure to a subsequent low dose of stress will elicit responses that dif-
fer from those elicited by the same amount of low-dose stress in a bal-
anced (i.e. healthy) biological system.
The homeostatic and homeorhetic adaptations, set in motion by
exposure and postexposure to severe and a low dose of stress, respec-
tively, are the processes that provide a link between a state of health
(salutogenesis or origin of health) and a state of disease (pathogenesis
or origin of disease). Salutogenesis is a stress orientated concept which
is focused on resources to maintain and improve a movement towards
health (Antonovsky 1979; Charlton 1996; Lindström and Eriksson
2005). Whereas pathogenesis is primarily concerned with the cause of
disease, salutogenesis pertains to the generation of a state of well-being
(Davies 2007). The interplay and shifting of balances between home-
ostasis, salutogenesis and pathogenesis facilitates maintenance of an
optimal state in the face of exposure to various amounts of stress.
Health is dependent on the balance between salutogenesis and patho-
genesis maintained by homeostasis (Davies 2007). This balance, in
turn, is affected by hormetic conditioning, such as pre- and postcondi-
tioning hormesis.
In an experimental setting, accurate assessment of postconditioning
hormesis involves 1). a sufficient amount of doses in the right quanti-
ties, 2). adequate dose spacing and 3). enough points in time for reli-
able evaluation (Calabrese 2008b). Often, assessment of postexposure
conditioning within a clinical framework is even more laborious and dif-
ficult to realize. For example, an accurate indication of the current state
of a particular biological system under study can be difficult to obtain.
Application of postexposure conditioning within a clinical context is
further complicated by the narrow window within which the inducing
agent may initiate protective effects. Outside the therapeutic window,
the postconditioning stress may become harmful. In addition, effective-
ness of the agent used to induce stress can alternate depending on the
biological system addressed and may differ, at the interindividual level,
even within one type of biological system (Thayer et al. 2005). Moreover,
low-dosage treatment with a particular harmful agent may profit one
individual but may inversely affect the population at large or other bio-
logical systems in its direct environment. Conversely, considering that
the dosage of stress is low, its effect is likely to be influenced by factors
from the environment (Thayer et al. 2005). Despite these complexities,
promising discoveries indicating the beneficial effects of exposing a bio-
logical system to a low adapting dose after a severe stress condition are
emerging from different scientific disciplines. The next section pro-
vides a number of examples that illustrate the clinical potential of pos-
texposure conditioning.
F.A.C. Wiegant and others
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POSTCONDITIONING HORMESIS: EXAMPLES FROM EXPERIMENTAL
AND CLINICAL RESEARCH
Postconditioning and Immunologic diseases
In immunology, postexposure conditioning has been related to the
therapeutic effects of treatment with adjuvants, allergens and pathogens.
This suggests a general principle. Particular types of adjuvants for exam-
ple, can be used to purposely infect rats thereby triggering systemic
inflammation. This stress can be greatly reduced by a subsequent injec-
tion of that same adjuvant in small doses. In this example of homologous
postconditioning hormesis, the therapeutic effect was long lasting and
antigen-specific because intraperitoneal aspecific inflammation, induced
by another adjuvant, did not prevent the disease (Bellavite et al. 2006b).
Allergen-specific immunotherapy reflects the principle of (homolo-
gous) postexposure conditioning hormesis. This therapy is based on
injecting patients suffering from allergies with increasing amounts of the
offending allergen in an attempt to reduce their level of sensitivity to
allergens (Bellavite et al. 2006b). For example, a case study on a patient
whose milk sensitivity was repeatedly confirmed by dietary challenge,
both blind and non-blind, reported sublingual milk therapy to be a suc-
cessful treatment (i.e., homologous postconditioning hormesis) (Rapp
1978). Rapp demonstrated that if the patient ingested excessive amounts
of milk and dairy products, the additional sublingual therapy relieved the
symptoms of the patient. Another study on specific immunotherapy sug-
gested clinical benefits for allergic asthma. The double-blind placebo
controlled trial indicated that immunotherapy modified the natural pro-
gression of asthma by improving lung function (Wang 2007).
In patients with a chronic viral infection, therapeutic vaccination
(homologous postconditioning hormesis) is aimed at modulating the
host immune response to become more effective against the particular
infection (i.e., reduce the level of susceptibility to the infection).
Depending on the virus, chronic infection has, presumably, modulated
the host immune response to become less effective against the invading
virus thereby promoting viral persistence (Sällberg et al. 2007). Injection
with additional material is thought to boost the immune response.
Already in the mid-1900’s, the bacillus Calmette-Guérin (BCG) vaccine
was used to treat established infection with tuberculosis (Plotkin 1999).
Other chronic viral infections that are considered possible targets for
therapeutic vaccination are the hepatitis B virus (HBV), the hepatitis C
virus (HCV) and human immunodeficiency virus (HIV-1) (Sällberg et al.
2007), which can be considered as a homologous postconditioning
hormetic strategy.
In 1985, Karpas and colleagues described the principle of passive
immunotherapy. HIV infected individuals received infusions of inacti-
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vated plasma collected from symptomless HIV infected individuals
(Karpas et al. 1985). Two studies, based on monthly infusions of this HIV-
positive inactivated plasma demonstrated a positive clinical effect
(Jackson et al. 1988; Karpas et al. 1988). Another study demonstrated the
benefit of passive immunotherapy based on transfusion every 14 days
during a period of one year. This treatment resulted in a delay of the
appearance of the first AIDS-defining event (Vittecoq et al. 1995). Since
the findings of Karpas and colleagues, both clinical observations and sys-
tematic trials related to homologous postconditioning hormesis have
suggested a correlation between a.) the goal of the immunotherapy, that
is, to decrease viral loads and increase CD4+ cell counts, and b.) the
decreased morbidity and mortality resulting from HIV-1 infection
(Connolly et al. 2008).
Postconditioning and Cardiovascular disease
Ischemic preconditioning and ischemic postconditioning demon-
strate consistent and clear cardioprotective effects utilized in every exper-
imental animal model (Liem et al. 2007). For example, the homologous
postexposure conditioning effect of repetitive ischemia applied during
early reperfusion in anesthetized open-chest dogs was cardioprotective by
attenuating reperfusion injury (Zhao et al. 2003). Postconditioning could
be an efficient cardioprotective intervention in patients with acute
myocardial infarction submitted to primary percutaneous coronary inter-
ventions (Darling et al. 2007; Laskey 2005; Staat et al. 2005). It has been
suggested that postconditioning protection for ischemia/reperfusion-
induced hypercontracture and cell death might be due to prolongation
of intracellular acidosis during initial reperfusion (Inserte et al. 2008).
Other studies have demonstrated that postconditioning can protect the
kidney from ischemia/reperfusion injury. Presumably, the mechanism
that involves protection of the mitochondrial respiratory chain function
is similar to the heart model (Serviddio et al. 2008). Other research has
indicated that postconditioning also reduces ischemic damage in the
brain. However, it remains to be elucidated whether or not this type of
postconditioning provides long-term protection and also improves neu-
rological function (Zhao 2007; 2009) or in myocardial infarction
(Skyschally et al. 2009).
Physical exercise is viewed as a potential non-pharmacological anti-
hypertensive treatment for diet-induced obesity hypertension
(Pinheiro et al. 2007). Low intensity exercise training has been report-
ed to attenuate the decrease in VO2max during the lifespan of a rat
(Tipton et al. 1983) and also decreases blood pressure in the majority
of patients with hypertension (Hagberg et al. 2000). In this example of
postconditioning hormesis, a temporary, moderate increase in blood
pressure, typically associated with exercise, results in improvement in
F.A.C. Wiegant and others
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hypertensive patients (i.e., an eventual decrease in blood pressure).
Research in both obese and non-obese rats supports the impression
that hypertension, subsequent cardiac hypertrophy, myocardial fibrosis
and myocardial vascularization improved in response to exercise train-
ing (Pinheiro et al. 2007).
Postconditioning and Cancer
Although harmful in high doses, radiation in low doses may stimulate
various immune functions that have the potential for clinical application
(Calabrese and Baldwin 2002b). For example, total-body irradiation
(TBI) in high doses is commonly used prior to bone marrow transplan-
tation due to its immunosuppressive effects, yet in low doses TBI has been
shown to suppress metastasis in tumor-bearing rats through various
immune-stimulating mechanisms (Hashimoto et al. 1999). Other
research supports the notion that low doses of TBI to mice may delay
tumor growth under certain conditions (Ito et al. 2008). In humans, low
dose radiation has been introduced as an effective therapy of non-
Hodgkin’s lymphoma (Girinsky et al. 2001; Kennerdell et al. 1999;
Richaud et al. 1998). Richaud and colleagues demonstrated that most
patients treated with low dose radiation showed an efficient response,
particularly with follicular lymphoma. In these patients, neither acute
nonlymphoblastic leukemia nor myelodysplasic syndrome was observed
with a median follow-up of 88 months.
Postconditioning and Neurological and Psychological diseases
Postconditioning hormesis has been therapeutically linked to treat-
ment of brain injury and psychological disorders. For example, glutamate
is the primary toxin released during brain injury. Several studies have
shown that treatment with low-dose glutamate can be used to reduce
brain injury after trauma (Ives et al. 2001; Jonas et al. 1999, 2001; Marotta
et al. 2002) thereby reflecting postconditioning hormesis.
In psychology, postconditioning hormesis is recognized in exposure
therapy for a wide variety of phobias. Exposure therapy is an effective
means of reducing negative affective symptoms associated with different
phobias (Rothbaum and Schwartz 2002). In recent experiments, phobic
subjects showed increased activity in the amygdala, a key brain structure
implicated in fear sensation. Two weeks after exposure therapy, a signifi-
cant reduction in hyperactivity at this location was recorded (Goossens et
al. 2007). These findings suggest a neural basis for modulating emotion-
al experience through systematic exposure to phobic stimuli (Hariri et al.
2000). A recent development in the treatment of phobias is virtual reali-
ty exposure therapy (VRET), a novel tool that has been shown to reduce
anxiety and phobia symptoms (Parsons and Rizzo 2008).
Postconditioning hormesis: an overview
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Postconditioning and Intoxication
Application of postconditioning hormesis also appears in the field of
toxicology. In an early multi-centred, double-blind study, administration
of low-dose mustard gas and an extract of the plant toxin Rhus toxicoden-
dron was suggested to modify local mustard-induced blistering and hasten
the rate of healing (Paterson 1944). Recently, research suggests that
exposure to sub-toxic, low-levels of toxic agents may stimulate a sufficient
protective response for both prevention and treatment of the effects
resulting from exposure to higher doses of toxin. This may provide an
alternative protective approach from biological and chemical agents
(Jonas and Ives 2008; Szeto et al. 2004).
DISCUSSION AND CONCLUSION
The generally accepted evolutionarily conserved phenomenon of
hormesis involving both low-dose stimulation and high-dose inhibition
has “evolved” over decades in many fields. Initially, hormesis had only
been identified with pre-exposure conditioning. Post-exposure condi-
tioning has only recently arrived into the field of hormesis and has there-
fore not yet reached a comparable level of acceptance in the scientific
world. Postconditioning hormesis involves administration of a low dose of
stress following exposure to a severe stress. Recently, the generality of this
phenomenon has been questioned, including whether beneficial effects
could be observed at the cellular level (Agutter 2008). This paper pres-
ents a number of reports from both “in vitro” cellular research and cur-
rent clinical research illustrating the relevance and therapeutic potential
of postconditioning hormesis.
In the current overview, examples of cellular, experimental and clin-
ical research are described from a phenomenological point of view. In
this overview, the observed phenomena are not explained in detailed
molecular or mechanistic terms. Although a number of papers have been
mentioned that speculate on the molecular basis of hormesis (Agutter
2008; Mattson 2008; Stebbing 2003), further studies are required to
understand the underlying mechanism of both pre- and post-condition-
ing hormesis. In this respect, it should be noted that an improved mech-
anistic understanding may require a recategorization of these phenome-
na in the future.
With respect to the possible underlying mechanism, it is speculated
that the initial severe stress affects the homeostatic (balanced) state of a
biological system and activates intrinsic self-recovery mechanisms.
Administration of a subsequent low dose stress may modulate or over-acti-
vate these recovery mechanisms attempting to cope with possible but
unpredictable encounters with (other) future stresses. Activation of these
adaptation strategies with a low dose stress can confer beneficial effects to
F.A.C. Wiegant and others
220
12
Dose-Response: An International Journal, Vol. 9 [2014], Iss. 2, Art. 5
https://scholarworks.umass.edu/dose_response/vol9/iss2/5
the biological system. Exactly which mechanisms underlie this phenome-
non remains elusive. However, the initial exposure alone, and/or com-
bined with post-exposure, activate homeostatic and homeorhetic adapta-
tions which provide a link between a state of health (salutogenesis) and a
state of disease (pathogenesis). The shifting between these states facili-
tates maintenance of optimal balance in the face of future exposure to
stress. Another aspect that requires further attention is both the concen-
tration as well as the nature in which the low dose stimulus should be
applied. With respect to the concentration, it has been shown that the
benefit of the low dose effect depends on the actual sensitivity of the bio-
logical system (Ovelgönne et al. 1995; Wiegant et al. 1999). In addition,
the ultramolecular dilutions that were shown to support recovery
(Paterson 1944; Ives et al. 2001; Jonas et al. 1999; 2001) is an aspect that
requires an explanation with respect to the nature of the information
transfer leading to a modulation of recovery mechanisms. Although the
underlying mechanisms in which recovery mechanisms are activated by
low doses remain obscure, promising results indicating the beneficial
effects of post-exposure conditioning are emerging from different scien-
tific disciplines. Further research in this field represents an interesting
challenge for both fundamental and clinical measurements.
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